跳转至内容
Merck
CN

SHC016

MISSION® pLKO.1-puro 非靶 shRNA 对照质粒DNA

Targets no known genes from any species

别名:

MISSION® 对照载体, shRNA对照, 阴性shRNA对照, 阴性对照, 非靶shRNA, 非靶shRNA对照, 非靶对照

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
41106609
NACRES:
NA.51
MDL number:
Concentration:
500 ng/μL in TE buffer; DNA (10μg of plasmid DNA)
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

Quality Level

product line

MISSION®

concentration

500 ng/μL in TE buffer; DNA (10μg of plasmid DNA)

shipped in

dry ice

storage temp.

−20°C

General description

MISSION pLKO.1-puro非靶标shRNA对照质粒DNA是一种慢病毒质粒载体。载体含有不靶向任何物种任何已知基因的shRNA(小发卡状RNA)插入片段,适合在使用MISSION shRNA文库克隆的实验中用作阴性对照。可用于检测转染的小发卡RNA对基因表达的影响,并解读shRNA克隆的敲低效应。氨苄青霉素和嘌呤霉素抗生素抗性基因分别用于细菌和哺乳动物细胞的选择性筛选。此外,利用表达载体与相容包装质粒共转染包装细胞(HEK293T),可生产自灭活复制缺陷病毒颗粒。非靶标shRNA对照质粒DNA产品为溶于Tris-EDTA(TE)缓冲液的500 ng/μl溶液,含有10 μg质粒DNA。

Application

MISSION® pLKO.1-puro非靶标shRNA对照质粒DNA已用作以下应用的转导对照:
  • 转导肿瘤细胞用于多色成像
  • 转导成人低钙诱导角质形成(HaCaT)细胞
  • 转导小鼠胚胎成纤维细胞,研究IP6K1(肌醇六磷酸激酶)的生物学功能
  • 研究星形胶质细胞分化中的Zac1(调节细胞凋亡和细胞周期阻滞的锌指蛋白)表达
想要查看更多应用数据、实验方案和载体图谱,请访问 sigma.com/shrna

Legal Information

使用本产品需遵守一个或多个许可协议。有关详细信息,请参阅http://sigmaaldrich.com/missionlicense
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

存储类别

10 - Combustible liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

常规特殊物品

此项目有


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Peroxiredoxin 2 nuclear levels are regulated by circadian clock synchronization in human keratinocytes
Avitabile D, et al.
The International Journal of Biochemistry & Cell Biology, 53(7580), 24-34 (2014)
Deletion of inositol hexakisphosphate kinase 1 (IP6K1) reduces cell migration and invasion, conferring protection from aerodigestive tract carcinoma in mice
Jadav RS, et al.
Cellular Signalling, 28(8), 1124-1136 (2016)
Brain tumour cells interconnect to a functional and resistant network
Osswald M, et al.
Nature, 528(7580), 93-93 (2015)
Murali R Kuracha et al.
PloS one, 12(6), e0179510-e0179510 (2017-06-24)
Mucinous colorectal adenocarcinomas (MCAs) are clinically and morphologically distinct from nonmucinous colorectal cancers (CRCs), show a distinct spectrum of genetic alterations (higher KRAS mutations, lower p53, high MUC2), exhibit more aggressive behavior (more prone to peritoneal dissemination and lymph node
Zac1 regulates astroglial differentiation of neural stem cells through Socs3
Schmidt EU, et al.
Stem Cells, 31(8), 1621-1632 (2013)

相关内容

全球贸易项目编号

货号GTIN
SHC016-1EA04061837018275

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持